Another study also reported that lapatinib, an anti-cancer drug developed by GlaxoSmithKline (GSK), which is used as a treatment for solid tumors such as breast and lung cancer was found to induce ANXA6 expression [41]. The gene discussed is ANXA6; the disease is lung carcinoma.